These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17696024)

  • 1. Clozapine-induced hypersalivation: a review of treatment strategies.
    Sockalingam S; Shammi C; Remington G
    Can J Psychiatry; 2007 Jun; 52(6):377-84. PubMed ID: 17696024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic chart review of pharmacological interventions in patients with clozapine-induced hypersalivation.
    Mutlu E; Özçelik Eroğlu E; Coşkun FÖ; Koçyiğit D; Canpolat İKN; Avcı H; Ertuğrul A; Anıl Yağcıoğlu AE
    Schizophr Res; 2024 Jun; 268():138-144. PubMed ID: 37597972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of clozapine-induced hypersalivation with ipratropium bromide: a randomized, double-blind, placebo-controlled crossover study.
    Sockalingam S; Shammi C; Remington G
    J Clin Psychiatry; 2009 Aug; 70(8):1114-9. PubMed ID: 19758522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and Comparison of the Effectiveness of Atropine Eye Drops, Ipratropium Bromide Nasal Spray, and Amitriptyline Tablet in the Management of Clozapine-Associated Sialorrhea in Patients With Refractory Schizophrenia: A Randomized Clinical Trial.
    Mohammad-Gholizad F; Karimzadeh I; Moghimi-Sarani E; Arshadi M; Mortazavi N
    J Clin Psychopharmacol; 2024 Jan-Feb 01; 44(1):9-15. PubMed ID: 38100776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study.
    Qurashi I; Chu S; Husain N; Drake RJ; Chaudhry I; Deakin JF
    Trials; 2016 Nov; 17(1):553. PubMed ID: 27871302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological strategies for clozapine-induced hypersalivation: treatment with botulinum toxin B in one patient and review of the literature].
    Kahl KG; Trillenberg P; Kordon A; Lencer R; Klein C; Hagenah J
    Nervenarzt; 2005 Feb; 76(2):205-8. PubMed ID: 15448913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine-induced hypersalivation.
    Davydov L; Botts SR
    Ann Pharmacother; 2000 May; 34(5):662-5. PubMed ID: 10852096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulpiride addition for the treatment of clozapine-induced hypersalivation: preliminary study.
    Kreinin A; Epshtein S; Sheinkman A; Tell E
    Isr J Psychiatry Relat Sci; 2005; 42(1):61-3. PubMed ID: 16134408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential use of ipatropium bromide for the treatment of clozapine-induced hypersalivation: a preliminary report.
    Calderon J; Rubin E; Sobota WL
    Int Clin Psychopharmacol; 2000 Jan; 15(1):49-52. PubMed ID: 10836287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (CIH).
    Livermore C; White H; Bailey L; Osborne I; Oloyede E; Dzahini O; Whiskey E
    BMC Psychiatry; 2022 Apr; 22(1):277. PubMed ID: 35443629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment options for drug-induced sialorrhea: Prescribing guidelines].
    Cuvelier E; Gressier B; Fovet T; Simon N; Décaudin B; Amad A
    Encephale; 2022 Dec; 48(6):700-711. PubMed ID: 35989107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is clonidine useful for treatment of clozapine-induced sialorrhea?
    Praharaj SK; Verma P; Roy D; Singh A
    J Psychopharmacol; 2005 Jul; 19(4):426-8. PubMed ID: 15983000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
    Croissant B; Hermann D; Olbrich R
    Pharmacopsychiatry; 2005 Jan; 38(1):38-9. PubMed ID: 15706466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of sublingual atropine sulfate on clozapine-induced hypersalivation: a multicentre, randomised placebo-controlled trial.
    Mubaslat O; Lambert T
    Psychopharmacology (Berl); 2020 Oct; 237(10):2905-2915. PubMed ID: 32876732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose Amisulpride for Debilitating Clozapine-induced Sialorrhea: Case Series and Review of Literature.
    Kulkarni RR
    Indian J Psychol Med; 2015; 37(4):446-8. PubMed ID: 26702180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation.
    Kreinin A; Miodownik C; Sokolik S; Shestakova D; Libov I; Bergman J; Lerner V
    World J Biol Psychiatry; 2011 Dec; 12(8):620-6. PubMed ID: 20964499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin as an effective treatment of clozapine-induced hypersalivation.
    Kahl KG; Hagenah J; Zapf S; Trillenberg P; Klein C; Lencer R
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):229-30. PubMed ID: 14747903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sublingual use of atropine for clozapine-induced sialorrhoea: literature review and two case reports].
    van der Poorten T; De Hert M
    Tijdschr Psychiatr; 2019; 61(6):403-410. PubMed ID: 31243750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine-induced sialorrhea: pathophysiology and management strategies.
    Praharaj SK; Arora M; Gandotra S
    Psychopharmacology (Berl); 2006 Apr; 185(3):265-73. PubMed ID: 16514524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyoscine for clozapine-induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial.
    Segev A; Evans A; Hodsoll J; Whiskey E; Sheriff RS; Shergill S; MacCabe JH
    Int Clin Psychopharmacol; 2019 Mar; 34(2):101-107. PubMed ID: 30614850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.